Trial Profile
A Phase I, Open-Label Study in Healthy Subjects to Explore the Potential for a Pharmacokinetic Interaction Between Steady-State Rilpivirine and a Single Dose Of Metformin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2014
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary) ; Metformin
- Indications Diabetes mellitus; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 01 Jan 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Dec 2012 New trial record